2:
N348I in the connection domain of HIV-1 reverse transcriptase confers zidovudine and nevirapine resistance.
Yap SH, Sheen CW, Fahey J, Zanin M, Tyssen D, Lima VD, Wynhoven B, Kuiper M, Sluis-Cremer N, Harrigan PR, Tachedjian G.
PLoS Med. 2007 Dec;4(12):e335.
PMID: 18052601 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC
9:
Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors.
Svicher V, Sing T, Santoro MM, Forbici F, Rodríguez-Barrios F, Bertoli A, Beerenwinkel N, Bellocchi MC, Gago F, d'Arminio Monforte A, Antinori A, Lengauer T, Ceccherini-Silberstein F, Perno CF.
J Virol. 2006 Jul;80(14):7186-98.
PMID: 16809324 [PubMed - indexed for MEDLINE]
Related Articles Free article in PMC